Timber Pharmaceuticals Inc (NYSE American:TMBR)

Delayed Data
As of 3:58pm ET
 -0.024 / -20.00%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Timber Pharmaceuticals Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +941.67% increase from the last price of 0.10.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Timber Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 73.33%
Growthannually 14.81%


Growthquarterly --
Growthannually -88.73%
Key to the earnings and sales forecast charts.